SNF Medication Regimen Review: A Complete Guide for Consultant Pharmacists

If you are a consultant pharmacist or a clinical pharmacy director serving skilled nursing and long-term care, the monthly medication regimen review (MRR) is the core of your work and your regulatory exposure. This guide walks through what an SNF medication regimen review covers, the clinical criteria you apply, the workflow that keeps you defensible in survey, and where the process usually breaks down. It is general professional education, not patient-specific clinical, legal, or billing advice.

What an SNF medication regimen review is

A medication regimen review is the systematic evaluation of each resident's medications to identify and address potential problems. In skilled nursing facilities (SNF), federal regulation requires that a licensed pharmacist review each resident's drug regimen and that identified irregularities be reported and acted on.

The review is not a formulary check or a billing audit. It is a clinical judgment exercise: you evaluate whether the regimen is appropriate, effective, and free of avoidable risk for that resident, and you document your reasoning so the interdisciplinary team can respond.

The specific requirements and the associated survey guidance (including the F-tags surveyors cite for unnecessary drugs, pharmacy services, and psychotropic use) are set by the Centers for Medicare & Medicaid Services (CMS). Requirements and interpretive guidance are periodically updated, so confirm current expectations directly with CMS at cms.gov and your state board of pharmacy rather than relying on any summary.

What the review should examine

A thorough SNF medication regimen review looks past the individual order to the whole regimen and the resident's clinical picture. In practice, the consultant pharmacist evaluates several recurring domains.

• Potentially inappropriate medications in older adults. The American Geriatrics Society (AGS) Beers Criteria flag drugs and drug classes that carry elevated risk in older adults. You apply them as decision support, weighing them against the resident's diagnoses and goals — not as an automatic stop order.
• Prescribing and deprescribing signals. The STOPP/START criteria (Screening Tool of Older Persons' Prescriptions / Screening Tool to Alert to Right Treatment) help identify both potentially inappropriate prescriptions and clinically indicated omissions.
• Anticholinergic burden (ACB). Cumulative anticholinergic load across a regimen is associated with cognitive and functional risk. You assess total burden, not just single agents.
• Psychotropics and gradual dose reduction (GDR). CMS expects documented attempts at gradual dose reduction and clear clinical rationale when antipsychotics and other psychotropics are continued. The consultant pharmacist evaluates whether the documentation supports continued use.
• Duplication, interactions, and monitoring gaps. Therapeutic duplication, significant drug interactions, missing lab or level monitoring, and duration-of-therapy concerns all belong in the review.
• Indication and effectiveness. Every drug should tie to a documented indication, and the regimen should show evidence that it is achieving its intended purpose.

Beers, STOPP/START, and anticholinergic scales are clinical tools updated on their own schedules. Treat each flag as a prompt for professional judgment applied to the individual resident, and confirm you are working from the current version of each criteria set.

The monthly SNF medication regimen review workflow

Most consultant pharmacists work on a recurring monthly cadence across an assigned census. A defensible workflow generally follows these steps.

1. Assemble the chart. Pull the current medication administration record, active orders, relevant diagnoses, recent labs, and progress notes. Fragmented source data is the most common cause of a slow, incomplete review.
2. Screen the regimen. Run the regimen against your clinical criteria — Beers, STOPP/START, anticholinergic burden, duplication, interactions, and monitoring — to surface candidates for closer review.
3. Apply clinical judgment. For each flag, decide whether it represents a genuine irregularity for this resident given diagnoses, goals of care, and response to therapy. Not every flag warrants a recommendation.
4. Write the recommendation. Document the finding, your clinical rationale, and a clear suggested action for the prescriber and interdisciplinary team. Specificity here is what makes the record defensible.
5. Sign and route. Apply your signature and route recommendations to the attending physician and director of nursing for response.
6. Close the loop. Track acceptance, rejection with rationale, or modification. An open recommendation with no documented response is a survey liability.

Documentation that holds up in survey

Surveyors do not just ask whether a review happened; they ask whether irregularities were identified, reported, and resolved. Strong documentation shares a few traits.

• Each recommendation states the specific medication, the concern, and the clinical basis in plain language.
• The rationale references the applicable criteria or principle rather than asserting a conclusion without support.
• The prescriber response is captured, including a documented rationale when a recommendation is declined.
• Timing is traceable — when the review occurred, when it was reported, and when it was resolved.
• The record is tamper-evident, so the sequence of events cannot be quietly rewritten after the fact.

An append-only audit trail matters here because "we reviewed it" is only credible if you can show what was reviewed, what was recommended, and what the facility did in response.

Where the process breaks down

The clinical criteria are public knowledge. The operational failure points are what cost consultant pharmacists time and expose facilities in survey.

• Data gathering. Hunting across systems and paper for orders, labs, and notes consumes a disproportionate share of review time.
• Inconsistent screening. Manual criteria checks vary reviewer to reviewer and month to month, which surfaces as gaps under scrutiny.
• Recommendation follow-through. Paper recommendations get lost, and unresolved items accumulate silently.
• Report bundling and billing. Assembling monthly reports per facility and then invoicing is manual, slow, and error-prone at the end of the cycle.

Addressing these does not change your clinical judgment — it protects the time you spend exercising it. You can see how the SNF-specific workflow fits together on the SNF and long-term care solution page.

How WeConsultRx helps

WeConsultRx gives consultant pharmacists AI-assisted SNF chart review backed by codified ASCP, Beers, and STOPP/START rule packs, so the routine screening across Beers, STOPP/START, and anticholinergic burden is surfaced consistently for every resident while you keep full clinical control of each recommendation. The platform pairs that synthesis with consultant e-signature, an append-only audit trail, monthly report bundles, and QuickBooks Online invoicing — replacing fragmented chart review and manual report assembly with one workflow. Explore the clinical engine and report features, or request a demo to see it against your own census.

Frequently asked questions